NEAT1 and systemic lupus erythematosus: Furthermore, NEAT1 was found to affect the expression of inflammatory chemokines and cytokines by activating the late mitogen-activated protein kinase (MAPK) signaling pathway, which could regulate the immune response of T and B cells, and participate in the development of SLE, thus providing a potential therapeutic target for SLE (37).